A carregar...
Effectiveness and Impact of the 4CMenB Vaccine against Group B Meningococcal Disease in Two Italian Regions Using Different Vaccination Schedules: A Five-Year Retrospective Observational Study (2014–2018)
Background: A few years after the introduction in Italy of a four-component anti-meningococcal B vaccine (4CMenB), we evaluated the effectiveness and impact of vaccination in two regions using different schedules (2, 4, 6, 12 months in Tuscany vs. 7, 9, 15 months in Veneto) through an observational...
Na minha lista:
| Publicado no: | Vaccines (Basel) |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7563708/ https://ncbi.nlm.nih.gov/pubmed/32842669 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines8030469 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|